Literature DB >> 23192270

Altered energy metabolism in cancer: a unique opportunity for therapeutic intervention.

Yi Zhang1, Jin-Ming Yang.   

Abstract

The early observations by Dr Otto Warburg revealed that fundamentally metabolic differences exist between malignant tumor cells and adjacent normal cells. Many studies have further reported the relationship between altered cellular metabolism and therapeutic outcomes. These observations suggest that targeting the peculiar metabolic pathways in cancer might be an effective strategy for cancer therapy. In recent years, investigations have accelerated into how altered cellular metabolism promotes tumor survival and growth. This review highlights the current concepts of altered metabolism in cancer and the molecular targets involved in glycolysis, mitochondria and glutamine metabolism and discusses future perspective of cellular metabolism-based cancer treatment.

Entities:  

Keywords:  cancer metabolism; cancer therapy; cell death; cell survival

Mesh:

Substances:

Year:  2012        PMID: 23192270      PMCID: PMC3572003          DOI: 10.4161/cbt.22958

Source DB:  PubMed          Journal:  Cancer Biol Ther        ISSN: 1538-4047            Impact factor:   4.742


  72 in total

Review 1.  Molecular imaging of cancer with positron emission tomography.

Authors:  Sanjiv Sam Gambhir
Journal:  Nat Rev Cancer       Date:  2002-09       Impact factor: 60.716

2.  Akt stimulates aerobic glycolysis in cancer cells.

Authors:  Rebecca L Elstrom; Daniel E Bauer; Monica Buzzai; Robyn Karnauskas; Marian H Harris; David R Plas; Hongming Zhuang; Ryan M Cinalli; Abass Alavi; Charles M Rudin; Craig B Thompson
Journal:  Cancer Res       Date:  2004-06-01       Impact factor: 12.701

3.  Overexpression of Glut1 and Glut3 in stage I nonsmall cell lung carcinoma is associated with poor survival.

Authors:  M Younes; R W Brown; M Stephenson; M Gondo; P T Cagle
Journal:  Cancer       Date:  1997-09-15       Impact factor: 6.860

4.  The role of glutamine in the oxidative metabolism of malignant cells.

Authors:  Z Kovacević; H P Morris
Journal:  Cancer Res       Date:  1972-02       Impact factor: 12.701

5.  Phase II study of L-asparaginase in the treatment of pancreatic carcinoma.

Authors:  H E Lessner; S Valenstein; R Kaplan; P DeSimone; A Yunis
Journal:  Cancer Treat Rep       Date:  1980

6.  Glucose and lipid metabolism in non-insulin-dependent diabetes. Effect of metformin.

Authors:  A Riccio; S Del Prato; S Vigili de Kreutzenberg; A Tiengo
Journal:  Diabete Metab       Date:  1991-05

7.  The pathways of glutamate and glutamine oxidation by tumor cell mitochondria. Role of mitochondrial NAD(P)+-dependent malic enzyme.

Authors:  R W Moreadith; A L Lehninger
Journal:  J Biol Chem       Date:  1984-05-25       Impact factor: 5.157

8.  Mitochondrial respiratory chain inhibitors induce apoptosis.

Authors:  E J Wolvetang; K L Johnson; K Krauer; S J Ralph; A W Linnane
Journal:  FEBS Lett       Date:  1994-02-14       Impact factor: 4.124

9.  Contributions of cell metabolism and H+ diffusion to the acidic pH of tumors.

Authors:  Paul A Schornack; Robert J Gillies
Journal:  Neoplasia       Date:  2003 Mar-Apr       Impact factor: 5.715

10.  Clinical significance of glucose transporter 1 (GLUT1) expression in human breast carcinoma.

Authors:  Sung Soo Kang; Yi Kyeong Chun; Min Hee Hur; Hae Kyung Lee; Yee Jeong Kim; Sung Ran Hong; Jee Hyun Lee; Sung Gong Lee; Yong Koo Park
Journal:  Jpn J Cancer Res       Date:  2002-10
View more
  53 in total

1.  Photodynamic Therapy with Hexa(sulfo-n-butyl)[60]Fullerene Against Sarcoma In Vitro and In Vivo.

Authors:  Chi Yu; Pinar Avci; Taizoon Canteenwala; Long Y Chiang; Bao J Chen; Michael R Hamblin
Journal:  J Nanosci Nanotechnol       Date:  2016-01

2.  The Carnitine Palmitoyl Transferase (CPT) System and Possible Relevance for Neuropsychiatric and Neurological Conditions.

Authors:  Ashraf Virmani; Luigi Pinto; Otto Bauermann; Saf Zerelli; Andreas Diedenhofen; Zbigniew K Binienda; Syed F Ali; Feike R van der Leij
Journal:  Mol Neurobiol       Date:  2015-06-04       Impact factor: 5.590

Review 3.  Pyruvate kinase M2: A simple molecule with complex functions.

Authors:  Mohammed Alquraishi; Dexter L Puckett; Dina S Alani; Amal S Humidat; Victoria D Frankel; Dallas R Donohoe; Jay Whelan; Ahmed Bettaieb
Journal:  Free Radic Biol Med       Date:  2019-08-08       Impact factor: 7.376

4.  Naringin suppresses the metabolism of A375 cells by inhibiting the phosphorylation of c-Src.

Authors:  Bingyu Guo; Yu Zhang; Qiang Hui; Hongyi Wang; Kai Tao
Journal:  Tumour Biol       Date:  2015-10-17

5.  Metabolic role of fatty acid binding protein 7 in mediating triple-negative breast cancer cell death via PPAR-α signaling.

Authors:  Soke Chee Kwong; Amira Hajirah Abd Jamil; Anthony Rhodes; Nur Aishah Taib; Ivy Chung
Journal:  J Lipid Res       Date:  2019-09-04       Impact factor: 5.922

6.  NAF-1 and mitoNEET are central to human breast cancer proliferation by maintaining mitochondrial homeostasis and promoting tumor growth.

Authors:  Yang-Sung Sohn; Sagi Tamir; Luhua Song; Dorit Michaeli; Imad Matouk; Andrea R Conlan; Yael Harir; Sarah H Holt; Vladimir Shulaev; Mark L Paddock; Abraham Hochberg; Ioav Z Cabanchick; José N Onuchic; Patricia A Jennings; Rachel Nechushtai; Ron Mittler
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-19       Impact factor: 11.205

7.  Gram-negative bacteria facilitate tumor outgrowth and metastasis by promoting lipid synthesis in lung cancer patients.

Authors:  Maosong Ye; Xia Gu; Yang Han; Meiling Jin; Tao Ren
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

Review 8.  Hypoxia and acidosis: immune suppressors and therapeutic targets.

Authors:  Sultan Damgaci; Arig Ibrahim-Hashim; Pedro M Enriquez-Navas; Shari Pilon-Thomas; Albert Guvenis; Robert J Gillies
Journal:  Immunology       Date:  2018-03-30       Impact factor: 7.397

9.  Aglycemia keeps mitochondrial oxidative phosphorylation under hypoxic conditions in HepG2 cells.

Authors:  Lydie Plecitá-Hlavatá; Jan Ježek; Petr Ježek
Journal:  J Bioenerg Biomembr       Date:  2015-10-08       Impact factor: 2.945

10.  Metabolic Disruption Early in Life is Associated With Latent Carcinogenic Activity of Dichloroacetic Acid in Mice.

Authors:  Leah C Wehmas; Anthony B DeAngelo; Susan D Hester; Brian N Chorley; Gleta Carswell; Greg R Olson; Michael H George; Julia H Carter; Sandra R Eldridge; Anna Fisher; Beena Vallanat; Charles E Wood
Journal:  Toxicol Sci       Date:  2017-10-01       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.